ELTX

Elicio Therapeutics, Inc.

Insider Trades

NameValueActionPriceCurrent Price
Chudnovsky YekaterinaDirector, 10 Percent Owner:
$20M3.4M shares
BuyAug 12, 2024
$5.81
--
Chudnovsky YekaterinaDirector, 10 Percent Owner:
$8.0M1.6M shares
BuyJun 28, 2024
$5.00
--
Venkatesan JayDirector
$250k50k shares
BuyJun 28, 2024
$5.00
--
Venkatesan JayDirector
$50050k shares
BuyJun 28, 2024
$0.01
--
Chudnovsky YekaterinaDirector, 10 Percent Owner:
$16k1.6M shares
BuyJun 28, 2024
$0.01
--

News

benzinga.comElicio Therapeutics Points To Durable Responses As It Maps Next Steps For Lead Cancer Drugbenzinga.comJun 17globenewswire.comElicio Therapeutics Reports Multiple Complete Responses After ELI-002 7P Treatment and Subsequent Therapy with Checkpoint Inhibition in Metastatic mKRAS Pancreatic Cancerglobenewswire.comJun 17prnewswire.comElicio Therapeutics Investigation Initiated: SueWallSt Investigates the Officers and Directors of Elicio Therapeutics (ELTX)prnewswire.comJun 16benzinga.comElicio Therapeutics Pancreatic Cancer Study Disappointsbenzinga.comJun 15globenewswire.comELTX INVESTOR ALERT: Holzer & Holzer, LLC Investigation of Elicio Therapeutics, Inc.globenewswire.comJun 15